The Manufacturers Life Insurance Company Sells 18,987 Shares of BWX Technologies, Inc. $BWXT

The Manufacturers Life Insurance Company lessened its holdings in BWX Technologies, Inc. (NYSE:BWXT) by 28.5% during the first quarter, Holdings Channel reports. The fund owned 47,543 shares of the technology company’s stock after selling 18,987 shares during the period. The Manufacturers Life Insurance Company’s holdings in BWX Technologies were worth $9,722,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. WFA of San Diego LLC acquired a new position in shares of BWX Technologies in the second quarter valued at $29,000. MV Capital Management Inc. acquired a new stake in shares of BWX Technologies during the 4th quarter worth about $32,000. Tucker Asset Management LLC acquired a new stake in shares of BWX Technologies during the 4th quarter worth about $36,000. Vermillion Wealth Management Inc. boosted its holdings in shares of BWX Technologies by 71.7% during the 4th quarter. Vermillion Wealth Management Inc. now owns 237 shares of the technology company’s stock worth $41,000 after buying an additional 99 shares during the period. Finally, Smithfield Trust Co boosted its holdings in shares of BWX Technologies by 52.1% during the 4th quarter. Smithfield Trust Co now owns 251 shares of the technology company’s stock worth $44,000 after buying an additional 86 shares during the period. 94.39% of the stock is owned by institutional investors.

BWX Technologies Stock Up 3.5%

NYSE BWXT opened at $174.64 on Tuesday. The company has a current ratio of 2.40, a quick ratio of 2.33 and a debt-to-equity ratio of 1.58. The company has a market cap of $16.00 billion, a price-to-earnings ratio of 46.70, a PEG ratio of 2.87 and a beta of 0.76. The company has a 50 day moving average of $187.47 and a 200-day moving average of $201.53. BWX Technologies, Inc. has a 1-year low of $149.57 and a 1-year high of $241.82.

BWX Technologies (NYSE:BWXT) last issued its quarterly earnings results on Monday, August 3rd. The technology company reported $1.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.04 by $0.03. BWX Technologies had a return on equity of 31.33% and a net margin of 10.20%.The business had revenue of $901.63 million for the quarter, compared to the consensus estimate of $902.80 million. During the same quarter in the prior year, the business posted $1.02 earnings per share. The firm’s quarterly revenue was up 18.0% compared to the same quarter last year. BWX Technologies has set its FY 2026 guidance at 4.700-4.800 EPS. On average, equities research analysts expect that BWX Technologies, Inc. will post 4.61 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, CEO Rex D. Geveden sold 10,000 shares of the firm’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $204.81, for a total value of $2,048,100.00. Following the transaction, the chief executive officer owned 202,491 shares in the company, valued at approximately $41,472,181.71. This trade represents a 4.71% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Michael Thomas Fitzgerald sold 2,417 shares of the firm’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $209.25, for a total value of $505,757.25. Following the completion of the transaction, the chief financial officer owned 6,884 shares in the company, valued at $1,440,477. The trade was a 25.99% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.60% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently commented on BWXT shares. JPMorgan Chase & Co. initiated coverage on shares of BWX Technologies in a research note on Monday, July 27th. They issued an “overweight” rating and a $230.00 price target on the stock. Seaport Research Partners upgraded BWX Technologies from a “neutral” rating to a “buy” rating and set a $245.00 price objective for the company in a report on Monday, June 22nd. Weiss Ratings downgraded BWX Technologies from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Wednesday, July 29th. Deutsche Bank Aktiengesellschaft raised BWX Technologies from a “hold” rating to a “buy” rating and upped their target price for the company from $205.00 to $255.00 in a research report on Friday, May 15th. Finally, Truist Financial lifted their price target on BWX Technologies from $205.00 to $212.00 and gave the stock a “hold” rating in a report on Monday, May 11th. Two research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $228.20.

Key Stories Impacting BWX Technologies

Here are the key news stories impacting BWX Technologies this week:

• Positive Sentiment: Second-quarter earnings beat expectations. BWXT reported adjusted earnings of $1.07 per share, ahead of analysts’ estimates of approximately $1.01-$1.04 and up from $1.02 a year earlier. Management cited strong execution, high growth in Commercial Operations and solid free-cash-flow generation. BWX Technologies Tops Q2 Earnings and Revenue Estimates
• Positive Sentiment: Full-year guidance was modestly raised relative to consensus. BWXT projected fiscal 2026 earnings of $4.70-$4.80 per share, slightly above the $4.69 analyst consensus. Revenue guidance of approximately $3.8 billion was broadly in line with expectations, reducing the risk of a major outlook reset. BWX Technologies Reports Second Quarter 2026 Results
• Positive Sentiment: BWXT agreed to sell its medical business to Nordic Capital. The transaction, valued at up to $800 million and including BWXT Medical and Kinectrics’ stable medical isotopes business, should generate liquidity while enabling BWXT to concentrate resources and capital on its core operations. BWXT will retain a minority stake in the new company. BWXT Selling Medical Business to Nordic Capital
• Neutral Sentiment: Revenue was essentially unchanged versus forecasts. Quarterly revenue of $901.6 million was slightly below one analyst estimate of $902.8 million, although other estimates characterized revenue as ahead of consensus. This modest variance is unlikely to outweigh the earnings beat and guidance.

BWX Technologies Company Profile

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.